LIXT
Lixte Biotechnology Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.11
-0.13 ▼ -4.01%
🌙 3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.11
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.18 | Insider Own | 2.35% | Shs Outstand | 0.01B | Perf Week | 27.46% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.01B | Perf Month | 1.63% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | - | Inst Own | 9.43% | Short Float | 1.05% | Perf Quarter | -26.3% |
| Income | -0.00B | P/S | - | EPS this Y | - | Inst Trans | 5.92% | Short Ratio | 1.1 | Perf Half Y | -40.99% |
| Sales | 0.00B | P/B | 7.52 | EPS next 5Y | - | ROA | -114.55% | Short Interest | 0.08M | Perf YTD | -20.87% |
| Book/sh | 0.41 | P/C | 4.67 | EPS past 3/5Y | 31.65% 6.1% | ROE | -130.06% | 52W High | -50.32% ($6.26) | Perf Year | 159.17% |
| Cash/sh | 0.67 | P/FCF | - | Sales past 3/5Y | - | ROIC | -84.15% | 52W Low | 385.94% ($0.64) | Perf 3Y | -56.38% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 33.89% | Gross Margin | - | Volatility(W/M) | 15.37% 9.64% | Perf 5Y | -92.88% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.32 | Perf 10Y | -78.4% |
| Dividend Ex-Date | - | Quick Ratio | 10.42 | EPS Q/Q | 24.93% | Profit Margin | - | RSI (14) | 52.98 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.42 | Sales Q/Q | - | SMA20 | 6.76% ($2.91) | Beta | 0.95 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -3.29% ($3.22) | Rel Volume | 0.16 | Prev Close | $3.24 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -14.68% ($3.65) | Avg Volume(3M) | 0.07M | Price | $3.11 |
| IPO | 2007/9/21 | Option/Short | No/Yes | Trades | 110 | Volume | 12,237 | Change | -4.01% |
뉴스 로딩 중...